GRHL2 expression functions in breast cancer aggressiveness and could serve as prognostic and diagnostic biomarker for breast cancer (vol 16, pg 1, 2022)

被引：0
|
作者：
Bai, Xiaoyu
Li, Yue
Li, Yanlei
Li, Fan
Che, Na
Ni, Chusheng
Zhao, Nan
Zhao, Xiulan
Liu, Tieju
机构：
来源：
CLINICAL MEDICINE INSIGHTS-ONCOLOGY | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TILRR (FREM1 isoform 2) is a prognostic biomarker correlated with immune infiltration in breast cancer
    Xu, Xiao-Yi
    Guo, Wen-Jing
    Pan, Shi-Hua
    Zhang, Ying
    Gao, Feng-Lin
    Wang, Jiang-Tao
    Zhang, Sheng
    Li, He-Ying
    Wang, Ren
    Zhang, Xiao
    AGING-US, 2020, 12 (19): : 19335 - 19351
  • [42] Eukaryotic Translation Initiation Factor 2 Subunit β as a Prognostic Biomarker Associates With Immune Cell Infiltration in Breast Cancer (vol 295, pg 753, 2024)
    Guo, Mengmeng
    Ying, Yu
    Chen, Yun
    Miao, Xian
    Cui, Haijing
    Yu, Zhenghong
    Wang, Xia
    JOURNAL OF SURGICAL RESEARCH, 2024, 300
  • [43] VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer
    Holding, Andrew N.
    Giorgi, Federico M.
    Donnelly, Amanda
    Cullen, Amy E.
    Nagarajan, Sankari
    Selth, Luke A.
    Markowetz, Florian
    GENOME BIOLOGY, 2019, 20 (1)
  • [44] Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo (vol 10, pg 41, 2016)
    Wang, Lan
    Wu, Jueheng
    Yuan, Jie
    Zhu, Xun
    Wu, Hongmei
    Li, Mengfeng
    FRONTIERS OF MEDICINE, 2021, 15 (06) : 942 - 942
  • [45] Expression of Concern: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation (Expression of Concern of Vol 210, Pg 951, 2015) (Publication with Expression of Concern. See vol. 219, 2022)
    Pichiorri, Flavia
    Palmieri, Dario
    De Luca, Luciana
    Consiglio, Jessica
    You, Jia
    Rocci, Alberto
    Talabere, Tiffany
    Piovan, Claudia
    Lagana, Alessandro
    Cascione, Luciano
    Guan, Jingwen
    Gasparini, Pierluigi
    Balatti, Veronica
    Nuovo, Gerard
    Coppola, Vincenzo
    Hofmeister, Craig C.
    Marcucci, Guido
    Byrd, John C.
    Volinia, Stefano
    Shapiro, Charles L.
    Freitas, Michael A.
    Croce, Carlo M.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 219 (11):
  • [46] Diagnostic and prognostic significance of FOXC1 expression in basal-like triple negative breast cancer
    Ray, P. S.
    Wang, J.
    Qu, Y.
    Shin-Sim, M.
    Shamonki, J.
    Bagaria, S. P.
    Liu, B.
    Elashoff, D.
    Hoon, D. S.
    Giuliano, A. E.
    Cui, X.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S21 - S21
  • [47] Correction: Carnitine palmitoyl transferase 1 A is a novel diagnostic and predictive biomarker for breast cancer (vol 21, 409, 2021)
    Tan, Zheqiong
    Zou, Yaru
    Zhu, Man
    Luo, Zhenzhao
    Wu, Tangwei
    Zheng, Chao
    Xie, Aqing
    Wang, Hui
    Fang, Shiqiang
    Liu, Shuiyi
    Li, Yong
    Lu, Zhongxin
    BMC CANCER, 2023, 23 (01)
  • [48] Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index (vol 12, pg 2468, 2006)
    Callagy, G. M.
    Pharoah, P. D.
    Pinder, S. E.
    CLINICAL CANCER RESEARCH, 2006, 12 (16) : 5002 - 5002
  • [49] Expression of Concern: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation (vol 210, pg 951, 2013) (Expression of Concern of Vol 219, art no E2012095009272022E, 2022)
    Pichiorri, Flavia
    Palmieri, Dario
    De Luca, Luciana
    Consiglio, Jessica
    You, Jia
    Rocci, Alberto
    Talabere, Tiffany
    Piovan, Claudia
    Lagana, Alessandro
    Cascione, Luciano
    Guan, Jingwen
    Gasparini, Pierluigi
    Balatti, Veronica
    Nuovo, Gerard
    Coppola, Vincenzo
    Hofmeister, Craig C.
    Marcucci, Guido
    Byrd, John C.
    Volinia, Stefano
    Shapiro, Charles L.
    Freitas, Michael A.
    Croce, Carlo M.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 219 (11):
  • [50] ASSESSMENT OF CIP2A AND ROCK-1 EXPRESSION AND THEIR PROGNOSTIC VALUE IN BREAST CANCER
    Osman, Nisreen Abdel Tawab
    Khalaf, Manal A.
    Ibraheem, Shaymaa A. S.
    POLISH JOURNAL OF PATHOLOGY, 2020, 71 (02) : 87 - 98
12345